However, as CKD advances, overt hyperphosphatemia ensues; as aforementioned, adaptive effects of FGF-23, PTH, and 1,25(OH)2D to enhance phosphate excretion are not able to overcome the phosphorus retention from continued dietary phosphorus intake and progressive reduction in glomerular filtration rate (GFR). The gene discussed is FGF23; the disease is chronic kidney disease.